000			01558 a2200469 4500
005			20250512034103.0
264		0	_c19860926
008			198609s 0 0 eng d
022			_a0065-4299
024	7		_a10.1007/BF01965006 _2doi
040			_aNLM _beng _cNLM
100	1		_aPaska, W
245	0	0	_aStudies on type II collagen induced arthritis in mice. _h[electronic resource]
260			_bAgents and actions _cJun 1986
300			_a413-20 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAmyloid _xblood
650	0	4	_aAnimals
650	0	4	_aAnti-Inflammatory Agents _xtherapeutic use
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aArthritis _xdrug therapy
650	0	4	_aArthritis, Experimental _xdrug therapy
650	0	4	_aAuranofin
650	0	4	_aAurothioglucose _xanalogs & derivatives
650	0	4	_aBCG Vaccine
650	0	4	_aCollagen
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aIndomethacin _xtherapeutic use
650	0	4	_aInflammation
650	0	4	_aMice
650	0	4	_aMice, Inbred DBA
650	0	4	_aMice, Inbred Strains
650	0	4	_aPrednisolone _xtherapeutic use
650	0	4	_aPropionates _xtherapeutic use
650	0	4	_aSerum Amyloid P-Component
650	0	4	_aSpecies Specificity
700	1		_aMcDonald, K J
700	1		_aCroft, M
773	0		_tAgents and actions _gvol. 18 _gno. 3-4 _gp. 413-20
856	4	0	_uhttps://doi.org/10.1007/BF01965006 _zAvailable from publisher's website
999			_c3098402 _d3098402